May Hill Capital »

United Therapeutics Corporation shares owned by May Hill Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by May Hill Capital from 13F filings

Historical chart of May Hill Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by May Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by May Hill Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $239k 490 487.25

More positions owned by May Hill Capital

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Etf (IWB)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Core Msci Emkt (IEMG)
Keysight Technologies (KEYS)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr National Mun Etf (MUB)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for May Hill Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Geode Capital Management
AQR Capital Management
Assetmark
Invesco
Norges Bank Investment Management
Dimensional Fund Advisors
Susquehanna International
Henderson Group
Citadel Advisors

View all funds holding United Therapeutics Corporation